Control to range for diabetes: functionality and modular architecture. - Wikidata - wikimedia - TriplyDB

Control to range for diabetes: functionality and modular architecture.

Control to range for diabetes: functionality and modular architecture.

http://www.wikidata.org/entity/Q30434937

about

Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement Treating type 1 diabetes: from strategies for insulin delivery to dual hormonal control Closed-loop insulin delivery for treatment of type 1 diabetes Heart rate informed artificial pancreas system enhances glycemic control during exercise in adolescents with T1D.Multinational Home Use of Closed-Loop Control Is Safe and Effective.Use of an artificial pancreas among adolescents for a missed snack bolus and an underestimated meal bolus.Modular closed-loop control of diabetes Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes.Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites.Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas.Diabetes technology: markers, monitoring, assessment, and control of blood glucose fluctuations in diabetes.Design of the health monitoring system for the artificial pancreas: low glucose prediction module Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia Artificial pancreas: past, present, future AP@home: a novel European approach to bring the artificial pancreas home.Hypoglycemia prevention via pump attenuation and red-yellow-green "traffic" lights using continuous glucose monitoring and insulin pump data Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events.Diabetes: Models, Signals, and Control.The artificial pancreas: current status and future prospects in the management of diabetes.Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial.Closed-loop insulin delivery in type 1 diabetes.Clinical evaluation of a personalized artificial pancreas.Diurnal pattern of insulin action in type 1 diabetes: implications for a closed-loop system.Closed-loop insulin delivery: from bench to clinical practice.Hypo- and Hyperglycemic Alarms: Devices and Algorithms.Challenges and Recent Progress in the Development of a Closed-loop Artificial Pancreas.Progress in development of an artificial pancreas Real-Time Detection of Infusion Site Failures in a Closed-Loop Artificial Pancreas.A quadruply-asymmetric sigmoid to describe the insulin-glucose relationship during intravenous insulin infusion.

P2860

Q26769878-50D74936-EC9C-49C0-BC0D-BA3F22E4E8F9 Q26853250-ACAB7ED8-3A39-4039-8C98-B8277A5BB318 Q27008127-8584945D-FB4D-439D-9ECF-E955E84E37BF Q30275746-CCFCC7AA-962B-4137-BE0E-2B2CB8B303C1 Q30276768-034B2CFE-B89E-4A38-8812-AE25F1FFF7E9 Q30301357-8B915F6D-F763-47F7-B6FF-86600AAC7F7D Q30370427-93CC72B5-1BB2-43F7-8E1C-7816AD2AE2C0 Q30370610-C568F1D7-55F4-40D9-B6F2-05598F07C3E7 Q30370613-B4382FDE-80AC-4269-A297-3E60A9B9E373 Q30412117-01E80887-ED36-448A-8D92-3A81CB2EDE64 Q30416241-CB33EC1E-EFF3-4391-BF75-474962140698 Q30416619-BD0DB1D5-2035-45CE-8231-060315DB6E1A Q30417379-EAA1145C-450C-433D-92ED-9FF68C26FD51 Q30424200-9555D3C4-C75E-4EA9-BBB6-446942F83E5B Q30424293-61D89622-1571-47E0-A9F5-03B350A828DB Q30430888-A189C4D8-728C-4994-8EA3-E4C1614D9927 Q30431605-9DDE950C-911E-4380-8ED8-5B7033B1320E Q30434551-CAA5A780-CCFF-45AE-92BE-674D16469CF0 Q33440813-9D38B14A-6E4D-46CA-BE4D-DF62C4C1A1E9 Q33454851-9F0535EC-B443-4823-B2BA-181495EAD6A2 Q35954124-2B34F704-BC23-43A5-8ED8-6A72FBA053A1 Q36720439-F1A1E636-CF63-4DC2-BA06-08632B02EBFC Q37014905-3A20F3B7-4347-4373-BC60-7D890E815E9F Q37846089-06054C32-E9DD-44B9-9E21-05BCB8CD7292 Q38452793-DC1D69B6-92AB-4F5B-8A9C-694E14A72BBA Q41458753-33A8DF89-4367-454D-A5B5-C31D6F5FFF23 Q42599316-62BA2BC7-1C8C-4DDC-BFDF-F360243A48F1 Q47553121-468C4DEA-418B-4663-8DA8-2E408ACE623C Q48875466-0FDEA50B-D6B7-4372-AF6F-50C056225882

P2860

Control to range for diabetes: functionality and modular architecture.

http://www.wikidata.org/entity/Q30434937

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Control to range for diabetes: functionality and modular architecture.

@ast

Control to range for diabetes: functionality and modular architecture.

@en

type

label

Control to range for diabetes: functionality and modular architecture.

@ast

Control to range for diabetes: functionality and modular architecture.

@en

prefLabel

Control to range for diabetes: functionality and modular architecture.

@ast

Control to range for diabetes: functionality and modular architecture.

@en

P1433

Q30434937-E9D5FDE9-AFF6-4440-9FC0-3CECF2C7334C

P1476

Q30434937-6497A27F-DD32-4D52-BF06-2ED7EBCA8BBE

P2093

Q30434937-347D1764-5C96-42F6-8542-B2878E274F15

Q30434937-37139764-113F-4C77-B6EA-645BF5A65242

Q30434937-3C04116B-FD4F-461F-B48E-8246CD352BA6

Q30434937-C1BEBB3E-901D-43B0-A7C9-4566485393C9

Q30434937-C36973C0-5ED9-4F49-85CA-CDF683BE5FFB

P2860

Q30434937-0FDED9BB-A242-4456-BBD2-84DDDA992E78

Q30434937-182ED206-0157-4924-B52A-FD624C7457D6

Q30434937-3CCBE1F6-6EBB-456F-9C8C-848F0F847E21

Q30434937-3F191F54-4945-4755-99F1-624FF7D0CC6B

Q30434937-42BB9494-EE61-4C0A-B0D3-0892F4B96B70

Q30434937-4670DF14-0274-465F-AEC6-6E8415ADD397

Q30434937-61866525-399E-478F-8F8E-23870F61FD6C

Q30434937-622CBEE2-F69A-41F1-9941-7B6064BA4A8F

Q30434937-66F87225-6545-4572-9128-91C5959AC9B1

Q30434937-7574B6AB-9916-408C-87B1-6C11BC311016

P304

Q30434937-CFF3FD1B-C75B-4FDE-86CA-669D297DBE5A

P31

Q30434937-180DA8B1-B66D-427F-8DF1-62713C2C1D23

P356

Q30434937-2F78126B-214D-450A-8EA6-45F0D7C82B7D

P433

Q30434937-A748F614-2EDA-4A18-B89F-7B46E6CC7074

P478

Q30434937-C1AFC285-DB34-4A63-8145-B56F4D2CA911

P50

Q30434937-140EDB63-0624-46C9-A609-4A8F45A5F6E8

Q30434937-3531D7A0-27B3-41C9-B80B-9120F68CF95B

Q30434937-A4C770B5-22D3-4599-9F23-CA2DA8FE2128

P577

Q30434937-EFFF6D7A-2761-42AF-84A2-A71C222010E2

P5875

Q30434937-82FFDAED-C170-4868-922D-E1CF9651B51E

P698

Q30434937-4D620B52-B46C-4847-A88F-378B6CD26447

P932

Q30434937-8768F6FD-A171-4006-978C-1514F22FC92C

P356

193229680900300509

P1433

Journal of Diabetes Science and Technology

P1476

Control to range for diabetes: functionality and modular architecture.

@en

P2093

Boris Kovatchev

http://www.w3.org/2001/XMLSchema#string

Giuseppe De Nicolao

http://www.w3.org/2001/XMLSchema#string

Juvenile Diabetes Research Foundation Artificial Pancreas Consortium

http://www.w3.org/2001/XMLSchema#string

Lalo Magni

http://www.w3.org/2001/XMLSchema#string

Stephen Patek

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience

Run-to-run tuning of model predictive control for type 1 diabetes subjects: in silico trial.

Statistical tools to analyze continuous glucose monitor data.

Evaluating the efficacy of closed-loop glucose regulation via control-variability grid analysis

Model predictive control of type 1 diabetes: an in silico trial

In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes.

Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes.

Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.

P304

1058-1065

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/193229680900300509

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Francis J. Doyle III

Claudio Cobelli

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41418831

http://www.w3.org/2001/XMLSchema#string

P698

20144419

http://www.w3.org/2001/XMLSchema#string

P932

2769910

http://www.w3.org/2001/XMLSchema#string